Robbinsville, NJ, January 5, 2010 – The Drug, Chemical and Associated Technology Association (DCAT), the PharmaChem industry’s premier business development association, is pleased to announce the addition of the following new member companies: Genepharm Group, Granules India, Ltd., Ordina Belgium, and Technology Catalysts International Corp. To learn about other DCAT member companies, visit DCAT’s Meet Our Members.
Genepharm Group is privately held and has been committed to the development, manufacturing and marketing of a premium range of generic pharmaceutical products since 1967. The Group’s development and manufacturing facilities are based in Athens, Greece. Genepharm develops, manufactures and markets a wide range of conventional and oncology generic medicines. www.genepharm.com
Granules India, Ltd.
Granules is a world class, large scale manufacturing company partnering with market leaders to offer pharmaceutical products and services. We have a long history as a producer of active pharmaceutical ingredients (APIs) and pharmaceutical formulation intermediates (PFIs) and recently expanded into finished dosages (FDs) through our state-of-the-art facility at Gagillapur. We support customers with unique value, extensive product range and a global network of associates. www.granulesindia.com
Ordina offers end-to-end solutions in consultancy, ICT and outsourcing. End-to-end solutions for the pharmaceutical industry include ERP, clinical supplies management, sample management, resource planning, manufacturing execution systems, portals, business intelligence and document management. On top, Ordina focuses on validation and quality assurance based on international legislation, recognized methodologies and standards. www.ordina.be
Technology Catalysts International Corp
TCI invests in complex generic products for FTF ANDAs and biosimilars, then either out-licenses or sells them directly to the trade. Complex generics include transplant drugs, injectables and depots, transdermal patches, oral thin films, complex orals, and biosimilar monoclonal antibodies, biosimilar fusion proteins, and biobetters. www.technology-catalysts.com
DCAT is the premier business development association whose membership is comprised of companies that manufacture, distribute or provide services to the pharmaceutical, chemical, nutritional and related industries.
DCAT Communications Coordinator